Product image of Midazolam Medical Valley (Midazolam) supplied by GNH India

Midazolam Medical Valley

Active Ingredient:
Midazolam
Origin:
EU

Midazolam Medical Valley (Midazolam)

Midazolam, the active ingredient in Midazolam Medical Valley, is a benzodiazepine presented as an oromucosal formulation for use in procedural sedation, anxiety relief, and seizure management in adult and pediatric patients. It acts on the central nervous system to produce rapid onset of calming and anticonvulsant effects, making it suitable for short‑term clinical interventions.

GNH India supplies Midazolam Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medical Valley Invest Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Midazolam is a benzodiazepine used in several clinical pathways that require rapid central nervous system depression.
  • Procedural sedation: provides calmness and amnesia during minor surgeries or diagnostic procedures.
  • Anxiety relief: reduces acute anxiety symptoms in pre‑operative or emergency settings.
  • Seizure management: terminates or prevents seizure activity when administered promptly.

How It Works

  • Midazolam enhances the inhibitory neurotransmitter gamma‑aminobutyric acid (GABA) by binding to the benzodiazepine site of the GABA‑A receptor complex. This increases chloride ion influx, hyperpolarizing neuronal membranes and leading to reduced neuronal excitability, which produces sedative, anxiolytic, anticonvulsant, and muscle‑relaxant effects.

Side Effects

Midazolam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Drowsiness or fatigue
  • Dizziness or light‑headedness
  • Amnesia for events surrounding administration
  • Mild hypotension
  • Transient respiratory depression

Serious or Rare Side Effects

  • Severe respiratory depression or apnea
  • Anaphylactic or hypersensitivity reactions
  • Paradoxical agitation or aggression
  • Cardiac arrhythmias or severe hypotension

Precautions & Warnings

  • When using Midazolam, clinicians should observe several safety measures to minimize risk.
  • Assess respiratory function: ensure adequate ventilation before administration.
  • Monitor blood pressure: watch for hypotension during and after dosing.
  • Avoid concurrent CNS depressants: limit use with opioids, alcohol, or other sedatives.
  • Use caution in elderly: start with lower doses due to increased sensitivity.
  • Adjust dose in hepatic impairment: reduce dosage as metabolism may be slowed.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Midazolam can interact with other medicines, altering its sedative effect or increasing toxicity.

Major Interactions (Avoid)

  • Opioids (e.g., morphine, fentanyl): additive respiratory depression.
  • Other benzodiazepines: excessive sedation and coma risk.
  • Barbiturates: profound CNS depression.
  • Macrolide antibiotics (e.g., erythromycin): may increase plasma levels.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): elevate midazolam concentrations.
  • CYP3A4 inducers (e.g., rifampicin): reduce effectiveness.
  • Antidepressants (e.g., fluoxetine): may enhance sedation.
  • Antihistamines (e.g., diphenhydramine): increase drowsiness.

Frequently Asked Questions

Midazolam Medical Valley is employed for procedural sedation, acute anxiety relief, and the rapid control of seizure activity. Its fast‑acting profile makes it suitable for short procedures, pre‑operative settings, and emergency seizure management when administered via the oromucosal route.

Midazolam binds to the benzodiazepine site on the GABA‑A receptor, enhancing the effect of the inhibitory neurotransmitter GABA. This increases chloride ion flow into neurons, hyperpolarising them and reducing neuronal firing, which results in sedation, anxiolysis, anticonvulsant activity, and muscle relaxation.

The specific dose of Midazolam Medical Valley is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and intended use. Healthcare professionals adjust the amount to achieve the desired level of sedation or seizure control while monitoring safety.

Safety data for Midazolam in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Midazolam has a rapid onset and short duration compared with longer‑acting benzodiazepines such as diazepam or lorazepam. This makes it preferable for brief procedures or emergency seizure control, whereas agents with longer half‑lives are often chosen for sustained sedation or anxiety management.

Midazolam Medical Valley should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain potency and stability.

Midazolam Medical Valley is formulated for oromucosal administration. The tablet or lozenge is placed in the mouth where it dissolves, allowing rapid absorption through the oral mucosa and providing quick onset of sedation or seizure control.

The most critical risks include severe respiratory depression, apnea, and rare anaphylactic reactions. Clinicians should monitor breathing and oxygen saturation continuously, especially when Midazolam is combined with other depressant agents.

Midazolam is contraindicated in patients with known hypersensitivity to benzodiazepines, severe respiratory insufficiency, acute narrow‑angle glaucoma, and those who are currently intoxicated with alcohol or other CNS depressants. Caution is also advised for individuals with significant hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Midazolam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT